IDXX
$354.76
Idexx Laboratories
$.56
.16%
IDXX
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $1.39
Revenue:  $666.70 Mil
Friday
Oct 30
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Friday, July 31, 2020

What do you expect when IDXX reports earnings?
Beat
Meet
Miss

Where is IDXX's stock price going from here?
Up
Flat
Down
Stock chart of IDXX
Analysts
Summary of analysts' recommendations for IDXX
Score
Grade
Pivots
Resistance
$372.00
$365.67
$360.21

$353.88

Support
$348.42
$342.09
$336.63
Tweet
Growth
Description
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk.
Peers
InterCeptRegeneron PharmaceuticalsBioMarin PharmaceuticalVertex PharmaceuticalsJohnson & JohnsonZoetisUltragenyx PharmaceuticalBristol-Myers SquibbCatalentMerck & Co.